To further test this idea, we first decreased the tumor cell invasiveness by depleting the endogenous Gα12, and then introduced recombinant IL-6 into the culture medium to determine if the cell invasiveness could be resumed by IL-6. This evidence concerns the gene IL6 and neoplasm.